Oxcarbazepine-induced hemolytic anemia in a geriatric patient

American Journal of Therapeutics

Volumn 15, Issue 2, 2008, Pages 187-189

  Chaudhry, Muhammad M ^a   Abrar, Maqsood ^a   Mutahir, Khan ^a   Mendoza, Concha ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

Anemia; Antiepileptics; Geriatric; Hemolytic; Side effects

Indexed keywords

OXCARBAZEPINE; PHENYTOIN;

AGED; AGITATION; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ERYTHROCYTE COUNT; FOLLOW UP; HEALTH STATUS; HEMOLYTIC ANEMIA; HUMAN; LABORATORY TEST; LETHARGY; MALE; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT;

AGED; ANEMIA, HEMOLYTIC; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; HUMANS; MALE;

EID: 41349115538     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31815afb6f     Document Type: Article

References (6)

1. Petz LD, Fudenberg HH. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med. 1966;274:171.
2. Logue GL, Boyd AE III, Rosse WF. Chlorpropamide-induced immune hemolytic anemia. N Engl J Med. 1970;83:900.
3. Worlledge SM, Carstairs KC, Dacie JV. Autoimmune haemolytic anaemia associated with methyldopa therapy. Lancet. 1966;2:135.
4. Hebbel RP, Eaton JW. Pathobiology of heme interaction with the erythrocyte membrane. Semin Hematol. 1989;26:1.
5. Beutler E. G6PD deficiency. Blood. 1994;84:3613.
6. Danielson C, Houseworth J, Skipworth E, et al. Arsine toxicity treated with red blood cell and plasma exchanges. Transfusion. 2006;46:1576.